Table 1.
Functional analysis for the differentially expressed genes in endometrium from women with adenomyosis compared with matched controls
| Top diseases and bio functions | P‐valuea | # of genes |
|---|---|---|
| Diseases and disorders | ||
| Neurological disease | 3.41 E−06 ‐ 2.57 E−30 | 67 |
| Organismal injury and abnormalities | 4.56 E−06 ‐ 2.57 E−30 | 336 |
| Connective tissue disorders | 2.97 E−06 ‐ 4.00 E−16 | 79 |
| Immunological disease | 3.40 E−06 ‐ 4.00 E−16 | 158 |
| Inflammatory disease | 3.14 E−06 ‐ 4.00 E−16 | 97 |
| Molecular and cellular functions | ||
| Cellular growth and proliferation | 4.48 E−06 ‐ 2.10 E−29 | 199 |
| Cellular movement | 4.48 E−06 ‐ 8.36 E−29 | 142 |
| Cell death and survival | 4.48 E−06 ‐ 1.45 E−26 | 177 |
| Cellular development | 4.48 E−06 ‐ 1.01 E−21 | 184 |
| Cellular function and maintenance | 4.31 E−06 ‐ 5.79 E−19 | 164 |
| Physiological system development and function | ||
| Tissue morphology | 4.04 E−06 ‐ 4.42 E−25 | 144 |
| Haematological system development and function | 4.48 E−06 ‐ 9.55 E−14 | 135 |
| Cardiovascular system development and function | 4.31 E−06 ‐ 3.63 E−19 | 110 |
| Organismal development | 6.43 E−14 ‐ 5.82 E−19 | 137 |
| Hematopoiesis | 3.54 E−06 ‐ 1.68 E−18 | 91 |
a
Range of P‐value indicates higher level functions that contained multiple lower level functions.